Found 4 matching trials
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
PHASE3The purpose of this study is to evaluate the efficacy and safety of standar...
Location
Investigative Site US058
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
PHASE1This study is conducted to determine the safety and tolerability of INCB161...
Location
Mayo Clinic Hospital
A Study to Evaluate INCB186748 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
PHASE1The purpose of this study is to evaluate INCB186748 in Participants With Ad...
Status
Active Not Recruiting
Location
UCLA Healthcare Hematology-Oncology
Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures
NAThe aim of this study is to assess the clinical value of 5 transcriptomic s...